Skip to main content

Table 2 Baseline clinical characteristics for the three groups

From: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

  1. Note: NAC, N-acetyl cysteine; CT, combination nutraceutical treatment; MADRS, Montgomery-Åsberg Depression Rating Scale; BDRS, Bipolar Depression Rating Scale; YMRS, Young Mania Rating Scale; HAM-A, Hamilton Anxiety Rating Scale; CGI-S Clinical Global Impressions - Severity Scale; ; SOFAS, Social and Occupational Assessment Scale; LIFE-RIFT, The Range of Impaired Functioning Tool; Q-LES-Q, Quality of Life